Novel piperidine derivative for the treatment of depression

Details for Australian Patent Application No. 2005267930 (hide)

Owner AstraZeneca AB

Inventors Hamley, Peter; Folmer, James; Wesolowski, Steven; Hunt, Simon Fraser

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005267930

PCT Pub. Number WO2006/014134

Priority 0401969-1 02.08.04 SE

Filing date 27 July 2005

Wipo publication date 9 February 2006

International Classifications

C07D 295/067 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/4453 (2006.01) - only substituted in position 1, e.g. propipocaine, diperodon

A61K 31/454 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 213/04 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 215/20 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 235/08 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 249/18 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 307/79 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/014134 Priority application(s): WO2006/014134

11 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005267931-Novel piperidine derivatives as histamine H3 receptor ligands for treatment of depression

2005267929-Diarylmethyl piperazine derivatives, preparations thereof and uses thereof